StockData
Prothena Corp Public Ltd Co logo

Prothena Corp Public Ltd Co (PRTA) stock

PRTANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3022% below fair value
$8.26+0.29 (+3.64%)

Close on Nov 17, 2026Market cap $424.04MP/E –Yield –

Prothena Corp Public operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Prothena Corp Public's operating cash flow for the twelve months ending Jun 30, 2026 was -$60.05M. For fiscal 2025 it was -$163.58M. The highest annual figure on record is $92.61M in fiscal 2021.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$163.58M–
FY2024Dec 31, 2024-$150.05M–
FY2023Dec 31, 2023-$133.91M–
FY2022Dec 31, 2022-$108.82M-217.5%
FY2021Dec 31, 2021$92.61M–
FY2020Dec 31, 2020-$80.36M–
FY2019Dec 31, 2019-$52.97M–
FY2018Dec 31, 2018-$28.28M–
FY2017Dec 31, 2017-$131.18M–
FY2016Dec 31, 2016-$116.25M–
FY2015Dec 31, 2015-$58.60M–
FY2014Dec 31, 2014-$683.00K–
FY2013Dec 31, 2013-$32.10M–
FY2012Dec 31, 2012-$42.07M–
FY2011Dec 31, 2011-$19.70M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$25.05M–
Q1 FY2026Mar 31, 2026$28.88M–
Q4 FY2025Dec 31, 2025-$23.31M–
Q3 FY2025Sep 30, 2025-$40.57M–
Q2 FY2025Jun 30, 2025-$46.34M-390.4%
Q1 FY2025Mar 31, 2025-$53.36M–
Q4 FY2024Dec 31, 2024-$47.77M–
Q3 FY2024Sep 30, 2024-$45.19M-574.8%
Q2 FY2024Jun 30, 2024$15.96M–
Q1 FY2024Mar 31, 2024-$73.05M–
Q4 FY2023Dec 31, 2023-$51.04M–
Q3 FY2023Sep 30, 2023$9.52M–
Q2 FY2023Jun 30, 2023-$44.93M–
Q1 FY2023Mar 31, 2023-$47.46M–
Q4 FY2022Dec 31, 2022-$4.98M–
Q3 FY2022Sep 30, 2022-$31.17M-127.8%
Q2 FY2022Jun 30, 2022-$35.26M-196.3%
Q1 FY2022Mar 31, 2022-$37.42M–
Q4 FY2021Dec 31, 2021-$22.46M–
Q3 FY2021Sep 30, 2021$112.11M–
Q2 FY2021Jun 30, 2021$36.62M–
Q1 FY2021Mar 31, 2021-$33.67M–
Q4 FY2020Dec 31, 2020-$19.09M–
Q3 FY2020Sep 30, 2020-$19.40M–
Q2 FY2020Jun 30, 2020-$18.70M–
Q1 FY2020Mar 31, 2020-$23.17M–
Q4 FY2019Dec 31, 2019-$14.49M–
Q3 FY2019Sep 30, 2019-$8.94M–
Q2 FY2019Jun 30, 2019-$12.10M-120.8%
Q1 FY2019Mar 31, 2019-$17.44M–
Q4 FY2018Dec 31, 2018-$21.25M–
Q3 FY2018Sep 30, 2018-$33.57M–
Q2 FY2018Jun 30, 2018$58.13M–
Q1 FY2018Mar 31, 2018-$31.58M–
Q4 FY2017Dec 31, 2017-$39.52M–
Q3 FY2017Sep 30, 2017-$17.74M–
Q2 FY2017Jun 30, 2017-$36.08M–
Q1 FY2017Mar 31, 2017-$37.84M–
Q4 FY2016Dec 31, 2016-$33.81M–
Q3 FY2016Sep 30, 2016-$30.06M–

More Prothena Corp Public figures

See a number that looks wrong?